drug interaction(s) of methotrexate with biological response modifier
Jump to navigation
Jump to search
Drug interactions
- use of methotrexate in combination with a biological response modifier increases risk of Herpes zoster (22 vs 9 per 1000 person-years)
More general terms
References
- ↑ Shalom G Systemic Therapy for Psoriasis and the Risk of Herpes Zoster. A 500,000 Person-year Study. JAMA Dermatol. Published online March 22, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25797026 <Internet> http://archderm.jamanetwork.com/article.aspx?articleid=2174887